Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00796575 · ClinicalTrials.gov registry record · Phase 1
Effects of Multiple Doses of CS-8080 in Healthy Volunteers
A Phase 1 study, sponsored by Daiichi Sankyo.
- Terminated
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT00796575 is a Phase 1 study that was terminated before completion, run by Daiichi Sankyo. The registered enrollment target is 16 participants.
The verdict
NCT00796575, a Phase 1 study, was terminated before completion, sponsored by Daiichi Sankyo.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The main purposes of this study are to assess the safety and measure the pharmacokinetics and pharmacodynamics of CS-8080 in healthy volunteers.
Interventions
- DRUG placebo tablets
- DRUG CS-8080
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2008-11 |
| Est. Completion | 2008-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00796575
The ClinicalTrials.gov registry entry for NCT00796575 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo tablets is the first listed.
NCT00796575 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00796575 about?
NCT00796575 is a clinical study titled "Effects of Multiple Doses of CS-8080 in Healthy Volunteers". The main purposes of this study are to assess the safety and measure the pharmacokinetics and pharmacodynamics of CS-8080 in healthy volunteers.
What is the current status of trial NCT00796575?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2008-11. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00796575?
The interventions under investigation include: placebo tablets (DRUG), CS-8080 (DRUG).
Who is sponsoring clinical trial NCT00796575?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.